Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal).
Read the full article on Wikipedia“Bevacizumab is a recombinant, humanized monoclonal antibody that functions as an angiogenesis inhibitor (inhibiting vascular endothelial growth factor A, VEGF-A). Its primary action is to inhibit the formation of new blood vessels (a process known as angiogenesis) which is essential for the progression of various types of cancer and thus considered a central target of modern cancer therapy.”
“20 days (range: 11–50 days)”
Working under the parallel aged-care framework? Aged-care equivalent →